I definitely feel LC is already being guided by large pharma(s) advice on these trials.
She may not know what exactly the large pharma's requirements are for our tech (for them to show $$$ interest), but based on her past experience at Genetech, she sure as hell knows how to extract the most out of these patients in-order to satisfy whatever data large pharma(s) are requesting of her and our tech.
Leslie Chong Interview 3, page-14
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.5¢ |
Change
-0.002(4.26%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 4.7¢ | 4.8¢ | 4.4¢ | $890.8K | 19.42M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 176601 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.6¢ | 969572 | 8 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
